51
TÍTULO: Chronopharmacology of nebicapone in healthy subjects.
AUTORES: Luis Almeida; Teresa Nunes; Ana I Loureiro; Carlos Fernandes Lopes; Leonel Torrao; Joana Maia; Eva Soares; Amilcar Falcao; Manuel Vaz da Silva; Lyndon Wright; Patricio Soares da Silva ;
PUBLICAÇÃO: 2006, FONTE: 35th Annual Meeting of the American-College-of-Clinical-Pharmacology in JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 46, NÚMERO: 9
INDEXADO EM: WOS
52
TÍTULO: siRNA delivery by transferrin associated lipoplexes: A novel non-viral strategy to mediate gene silencing in neurons  Full Text
AUTORES: Cardoso, AL; Pelisek, J; Almeida, LP; Simoes, S; Plesnila, N; Wagner, E; de Lima, MCP; Culmsee, C;
PUBLICAÇÃO: 2006, FONTE: 47th Spring Meeting of the Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und-Toxikologie in NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, VOLUME: 372
INDEXADO EM: WOS
53
TÍTULO: Inhibition mechanisms of mitochondrial permeability transition by 4-hydroxytamoxifen: Protection of NAD(P)H and thiol group oxidation  Full Text
AUTORES: Cardoso, CMP; Almeida, LM; Custodio, JBA ;
PUBLICAÇÃO: 2005, FONTE: TOXICOLOGY MECHANISMS AND METHODS, VOLUME: 15, NÚMERO: 2
INDEXADO EM: Scopus WOS CrossRef
54
TÍTULO: Kinetics and thermodynamics of lipid amphiphile exchange between lipoproteins and albumin in serum
AUTORES: Estronca, LMBB ; Moreno, MJ ; Laranjinha, JAN ; Almeida, LM; Vaz, WLC ;
PUBLICAÇÃO: 2005, FONTE: BIOPHYSICAL JOURNAL, VOLUME: 88, NÚMERO: 1
INDEXADO EM: Scopus WOS CrossRef: 25
55
TÍTULO: Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular risk
AUTORES: Reis, F ; Campos, MV; Bastos, M; Almeida, L; Lourenco, M; Ferrer Antunes, CA; Palmeiro, A; Santos Dias, JD; Mesquita, JF; Carvalheiro, M; Teixeira, F ;
PUBLICAÇÃO: 2005, FONTE: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, VOLUME: 90, NÚMERO: 1
INDEXADO EM: Scopus WOS CrossRef: 3
56
TÍTULO: Lentiviral vectors for gene silencing in polyglutamine disorders: ataxin 3 gene silencing by lentiviral-mediated delivery of double-stranded RNAs  Full Text
AUTORES: Alves, S; Deglon, N; de Almeida, LP;
PUBLICAÇÃO: 2004, FONTE: 2nd European Conference and Practical Course on Towards Clinical Gene Therapy - Preclinical Gene Transfer Assessment in GENE THERAPY, VOLUME: 11
INDEXADO EM: WOS
58
TÍTULO: Protection of tamoxifen against oxidation of mitochondrial thiols and NAD(P)H underlying the permeability transition induced by prooxidants  Full Text
AUTORES: Cardoso, CMP; Almeida, LM; Custodio, JBA ;
PUBLICAÇÃO: 2004, FONTE: CHEMICO-BIOLOGICAL INTERACTIONS, VOLUME: 148, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef: 14
59
TÍTULO: Comparison of the changes in adenine nucleotides of rat liver mitochondria induced by tamoxifen and 4-hydroxytamoxifen  Full Text
AUTORES: Cardoso, CMP; Moreno, AJM ; Almeida, LM; Custodio, JBA ;
PUBLICAÇÃO: 2003, FONTE: 12th International Workshop on In Vitro Toxicology in TOXICOLOGY IN VITRO, VOLUME: 17, NÚMERO: 5-6
INDEXADO EM: Scopus WOS CrossRef: 21
60
TÍTULO: Dose-dependent neuroprotective effect of CNTF delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease
AUTORES: Deglon, N; Regulier, E; de Almeida, LP; Sommer, B; Aebischer, P;
PUBLICAÇÃO: 2003, FONTE: 13th Meeting of the Network of European CNS Transplantation and Restoration (NECTAR) in CELL TRANSPLANTATION, VOLUME: 12, NÚMERO: 3
INDEXADO EM: WOS
Página 6 de 10. Total de resultados: 94.